BALAJI VENKATARAMAN

CIK 1114916 · Chief Executive Officer · last filed 2023-08-17

BALAJI VENKATARAMAN is a Chief Executive Officer who has filed 5 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing shows the insider converted $150.4M of ALIM on Aug 17, 2023. Across all open-market trades the lifetime net is −$69.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $30.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$30.8K

Companies

5

Total Filings

5

Lifetime Open-Market Net

-$69.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
ALIMERA SCIENCES INC (ALIM) Delisted	10%+ Owner	9,429,808	$5.54	$52.24M	$0	1	2023-08-17
JSPRW		2,300,000	$0.01	$30.8K	$0	1	2021-09-28
Jasper Therapeutics, Inc. (AMHCU) Delisted	Chief Executive Officer	—	$16.28	—	$0	1	2020-01-07
PROGENICS PHARMACEUTICALS INC (PGNX) Delisted	10%+ Owner	8,011,733	—	—	$1.08M	1	2019-09-11
Horizon Therapeutics Public Ltd Co (HZNP) Delisted		10,499,360	$116.30	$1.22B	-$70.24M	1	2014-11-17

Recent Filings

5 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2023-08-17	ALIMERA SCIENCES INC (ALIM) Delisted	Conv (C)	+83,642,153	$150.38M	EDGAR
2021-09-28	JSPRW	Mixed	+2,300,000	$0	EDGAR
2020-01-07	Jasper Therapeutics, Inc. (AMHCU) Delisted	Other (J)	—	$0	EDGAR
2019-09-11	PROGENICS PHARMACEUTICALS INC (PGNX) Delisted	Buy (P)	+216,069	$1.08M	EDGAR
2014-11-17	Horizon Therapeutics Public Ltd Co (HZNP) Delisted	Sell (S)	−6,086,957	-$70.24M	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.